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Background: Adverse events are unintended patient injuries that arise from healthcare management resulting in
disability, prolonged hospital stay or death. Adverse events that require intensive care admission imply a
considerable financial burden to the healthcare system. The epidemiology of adverse events in Belgian hospitals
has never been assessed systematically.
Findings: A multistage retrospective review study of patients requiring a transfer to a higher level of care will be
conducted in six hospitals in the province of Limburg. Patient records are reviewed starting from January 2012 by a
clinical team consisting of a research nurse, a physician and a clinical pharmacist. Besides the incidence and the
level of causation and preventability, also the type of adverse events and their consequences (patient harm,
mortality and length of stay) will be assessed. Moreover, the adequacy of the patient records and quality/usefulness
of the method of medical record review will be evaluated.
Discussion: This paper describes the rationale for a retrospective review study of adverse events that necessitate a
higher level of care. More specifically, we are particularly interested in increasing our understanding in the
preventability and root causes of these events in order to implement improvement strategies. Attention is paid to
the strengths and limitations of the study design.
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Background
An important indicator of patient safety is the rate of ad-
verse events in hospitals. An Adverse event can be defined
as (1) an unintended injury or complication, (2) which
results in disability at discharge, death or prolongation of
hospital stay, and (3) is caused by healthcare management
(including omissions) rather the patient’s disease [1-5]. Al-
though all medical errors should be a concern, errors that
either result in serious consequences for patients or that
are preventable are of particular concern. A substantial* Correspondence: annemie.vlayen@uhasselt.be
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reproduction in any medium, provided the ornumber of adverse events is detected among unintended
Intensive Care Unit (ICU) admissions and readmissions.
Unplanned Intensive Care Admission (UIA) is an existing
clinical indicator, used in several countries on a regular
basis. It was developed and implemented in Australia, in
a close collaboration between the Australian and New
Zealand College of Anaesthetists (ANZCA) and the Aus-
tralian Council on Healthcare Standards (ACHS) and
recommended as a measure of patient safety (“avoidable
incidents in anaesthesia”) and the effectiveness of care
(“lack of planning”) [6].
To estimate the incidence and preventability of adverse
events requiring ICU (re)admission, we conducted a sys-
tematic review including medical record review studies
[7]. A total of 27 studies were included, of which 14Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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aesthetic or surgical adverse events, eight studies investi-
gated adverse events on general wards and five studies
focused on ICU readmissions. Due to study heterogeneity,
meta-analysis of the data was not appropriate. Results
showed that the percentage of surgical and medical ad-
verse events requiring ICU admission ranged from 1.1%
to 37.2%. ICU readmissions varied from 0% to 18.3%. Pre-
ventability of the adverse events varied from 17% to
76.5%. Consequences of the adverse events included a
mean length of ICU stay that ranged from 1.5 days to
10.4 days for the patient’s first stay in ICU and mortality
percentages between 0% and 58%. The large variation in
study outcomes can be explained by methodological diver-
sity. The included studies varied in sample size, applied
different methods of screening and only three out of 27
studies used a multi-center design. On the other hand,
clinical diversity was high because of population mix and
variation (or absence) of definitions on adverse outcomes.
As a conclusion, we suggest that planning of future studies
should aim to standardize terminology and measures of
outcomes (standard taxonomy) and to apply more explicit
study designs in order to allow for comparisons across
studies.
Several nationwide studies describe the use of medical
record review to measure the occurrence of adverse
events in hospitals [1-4,8-11]. ‘Unplanned transfer from
general to intensive care’ is often used as a criterion (‘trig-
ger’ or clue) to uncover adverse events and medical errors
[2,4,8,10,12]. The positive predictive value (PPV) reflecting
the reliability of this screening criterion varies from 1.9%
[10] - 3.1% [4] to 6.5% [2]. Basically, the process of med-
ical record review involves a multi-stage record review in
which in the first stage the records are assessed by trained
nurses for the presence of a predefined set of explicit cri-
teria, indicating a potential adverse event. Each record that
is positive for one or more criteria is forwarded to the next
stage and reviewed by physicians for confirmation. The as-
sessment of causation and preventability is performed
using classification scales. Modifications in methodology
among these studies involve different screening criteria,
the reviewers’ education, definitions, timeframe of in-
cluded events or the assessment of causation and prevent-
ability [1,2,4,9,11].
In Belgium, the occurrence of adverse events has never
been assessed through medical record review. Retro-
spective analysis of the national hospital discharge data-
set of all Belgian acute hospitals for the year 2000
estimated the incidence of adverse outcomes to be 7.12%
for medical and 6.32% for surgical hospital stays, with a
high variability between hospitals [13].
Currently, there are 194 Belgian hospitals, of which 105
acute, 66 psychiatric and 23 long-term care hospitals.
Acute hospitals consist of university hospitals, generalhospitals ‘with university character’ and other non-
university hospitals. Belgium has seven university hospi-
tals, one for each medical school that offers the entire
medical education. The Flemish region of Belgium has 55
acute hospitals. The province of Limburg, which is a part
of the Flemish region, has seven acute hospitals, of which
two hospitals with a university character [14]. This multi-
center study is initialized in the province of Limburg and
aims at identifying preventable adverse events that con-
tributed to the transfer of patients to a higher level of care
using the method of chart review. This study is funded by
‘Limburg Sterk Merk’, a foundation of public use that sup-
ports healthcare and economic development projects.
It is not in the purpose of this study to detect all the
adverse events in the inpatient records. An important
goal is to make a clear distinction between the causality
(errors) and the consequences (patient harm) of the ad-
verse events. Rating preventability is important in under-
standing the system specific aspects of health care
processes in order to design preventive or mitigating
barriers.
The objectives of this multicenter study are to:
1. Determine the incidence of adverse events requiring
a transfer to a higher level of care;
2. Assess the preventability of these adverse events;
3. Assess the clinical impact of these events;
4. Evaluate the adequacy and completeness of the
patient charts;
5. Evaluate the use of medical record review as an
auditing tool.
Spin-off studies will be undertaken to:
1. Explore the clinical and system specific causes of
these adverse events and gain insight into potential
preventive strategies (Root Cause Analysis); and




A retrospective cohort study will be undertaken in six
acute hospitals in the province of Limburg. All acute
hospitals from the province of Limburg were invited to
participate in this study. Six out of seven hospitals con-
firmed their participation and gave permission to access
their patient charts.
Type of participants and record selection
To minimize selection bias, all records of the patients
being transferred to a higher level of care and being dis-
charged from or deceased in the hospital during the inclu-
sion period (November 2011 - May 2012), irrespective the
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the occurrence of adverse events. In practice, record selec-
tion is based on (1) (re)admission to the Intensive Care
Unit from other care units in the hospital providing lower
intensity care, (2) an intervention by a Medical Emergency
Team (MET) due to an unanticipated change in the
patient’s clinical status or (3) a redo procedure within
24 hours for ICU patients. Considering that record selec-
tion is not based on routine hospital registration, hospitals
were instructed to select the cases using a uniform selec-
tion form.
Because of their specific nature, patients admitted on
neonatal or maternal ICUs will be excluded. Also
planned admissions to the ICU from the operation room
(major elective surgery) and ICU admissions directly
from the emergency department will be excluded. As the
included hospitals have no pediatric ICUs, only patients
from the age of 16 or over will be included.
Starting from January 2012, patient records will be
reviewed in a multistage review process by a research
nurse (holder of a specialization degree in Intensive Care/
Emergency care), a physician (holder of a specialization
degree in Anesthesiology/ Urgent and Emergency Medi-
cine) and a clinical pharmacist. Chart review will be per-
formed once the entire -closed and complete- record is
available to the reviewers. A complete record consists of a
medical (including laboratory and radiology results), nurs-
ing and pharmaceutical record. However, medical reports
that are found to be incomplete or ambiguous are also
included in the review process, as exactly in these cases
the possibility of containing adverse events might be
higher [15]. The review period is accomplished when all
the included records are reviewed. It is expected that theFigure 1 Sample size calculation. Abbreviations: CI, Confidence Interval;period between record selection and review is relatively
short and is largely dependent on (1) the length of stay
from the time of transfer to a higher level of care and (2)
the date of availability of the medical records. It is also
expected that the structure of the records will not be uni-
form in all participating hospitals.Power calculation
The main (numerical) objective of this study is to esti-
mate an overall incidence rate of adverse events (number
of adverse events/patient days at risk). It is not in the
aim to compare the results of the participating hospitals.
The precision of this estimate will be provided by a
95% confidence interval. The sample size of this study is
determined in order to guarantee a sufficiently narrow
confidence interval for the estimate.
From a pilot study of two months, 66 patients with
one or more adverse events leading to a higher level of
care were detected for 44 165 days at risk (149 per 100
000 patient days at risk) (Figure 1). At this rate, a sample
size of 100 000 patient days at risk would provide a con-
fidence interval of approximately 20% (+/− 10% around
the estimate). As the total yearly number of in- patient
days (excluding palliative, neonatal, pediatric and one
day-stay admissions) for the six participating hospitals is
76 0057 (year 2010), this sample size corresponds to an
inclusion period of six to seven months.
Different levels of clustering can be considered in this
study: hospital level, ward level, pathology level, individ-
ual patient level. Since little is known about the impact
of these different levels of clustering, clustering is not
considered in calculating the sample size.AE, Adverse Event.
Vlayen et al. BMC Research Notes 2012, 5:468 Page 4 of 9
http://www.biomedcentral.com/1756-0500/5/468Outcome measures
Primary outcome measures are the number of patients
transferred to a higher level of care because of an adverse
event -or a combination of adverse events- per 100 000
patient days at risk, and the number of preventable ad-
verse events in comparison with the number of adverse
events. The number of patient days at risk is calculated as
the total number of hospitalization days in the participat-
ing hospitals during the study period (excluding palliative,
neonatal, pediatric and day-stay admissions).
Secondary outcomes are the type of event (operative,
procedural, diagnostic, therapeutic, drug/ intravenous
fluid or system issue), attributable causes and conse-
quences of the events (level of patient harm, mortality and
length of stay in hospital and ICU).
Independent variables are presented in a non-exhaustive
list in Table 1.
Definitions
The definitions are adopted from previous adverse
events studies [4,10,11,16-18]. They are described in
Table 2.
Data collection and review process
In each hospital, the patient records will be reviewed in
a multistage review process (Figure 2, based on Zegers,
2007) [5].
Stage 1: Selection of charts A master list of eligible
patients is generated at each hospital from the hospital ad-
ministrative database by the quality coordinator using a
uniform selection form across hospitals. Patient records
selection is based on (1) an unplanned ICU admission, (2)Table 1 Independent variables
– Primary diagnosis for admission to the hospital
– Patient history
– Patient age (in years); year of birth
– Gender
– Number of prescribed drugs before hospital admission
– Admission day and time to ICU
– ICU admission source (location/ providers of care)
– Length of total hospital stay (prior to ICU admission) (LOS) (in days)
– Length of ICU stay (in days)
– Outcome in the ICU (discharge, mortality)
– Acute Physiology and Chronic Health Evaluation (APACHE) II
Patient complexity and mortality risk are defined according to the All
Patient Refined Diagnosis Related Groups, which is calculated based on
patient diagnosis, procedure, and age using a scale of 1 (least complex/
lowest risk) to 4 (most complex/highest risk).
– Quality and completeness of the medical records
– Time measures screening processa MET intervention or (3) a redo procedure within
24 hours for ICU patients. ICU admissions are registered
on the ICUs, while MET interventions are registered on
the emergency departments. Only closed patient records
(after discharge from the hospital or decease of the pa-
tient) are forwarded to the next stage.
Stage 2: Chart review for adverse events First, the re-
search nurse collects from the patient records data on
basic patient characteristics (gender, year of birth, reason
for hospital intake, reason for transfer to ICU, number
of days in the hospital prior to ICU transfer, admission
day and time to ICU, number of prescribed drugs before
hospital admission, ICU admission source (location/
providers of care) and outcome in ICU. The research
nurse notes the data in a structured abstraction instru-
ment, which was developed for this study.
Subsequently, each record will be reviewed by the clin-
ical team to determine if an adverse event occurred
according to the definition of Wilson (Table 2). Although
each of the persons of the clinical team has a specific
focus during the chart review, respectively the medical
record (physician), the nurse record (research nurse) and
the pharmacologic record (clinical pharmacist), assess-
ments are made collectively. The medical records are
reviewed using the structured abstraction instrument to
standardize the judgements of the reviewers.
In order to evaluate the process of medical record re-
view, data on the quality and completeness of the med-
ical records, missing records and time measures of the
screening processes are recorded. An important criterion
is the recording of the actual reason for the transfer to a
higher level of care.
Stage 3: Consensus judgment on occurrence, prevent-
ability and harm The members of the clinical team
compare their findings and come to consensus on the
occurrence of an adverse event. Once the team con-
cludes on an the occurrence of the event, the assessment
on preventability and severity ratings is performed by
consensus judgment.
The assessment of causation is performed using a scale
from 1 to 6 (Table 3). Upon ratings of at least 4 (i.e. more
than 50% likelihood), unintended injuries or complications
are classified as adverse events. If the clinicians identify an
adverse event, the review is continued with an assessment
of its preventability using a similar six-point scale grouped
into categories: no preventability, low and high evidence of
preventability (Table 3). Further classification is done by
type of adverse event [4,19] and patient harm (severity cat-
egories) (Table 3). The severity categories of the adverse
events identified are based on the classification of the Na-
tional Coordinating Council for Medication Error Report-
ing and Prevention (NCC MERP) [20]. The classification
Table 2 Definitions
Adverse event (1) An unintended injury or complication, which results in (2) disability at discharge, death or prolongation of hospital
stay, and (3) is caused by healthcare management (including omissions) rather than the patient’s disease [4].
Unintended injury Refers to any disadvantage for the patient that leads to prolonged or strengthened treatment, temporary or
permanent (physical or mental) impairment or death [11].
Disability Refers to temporary or permanent impairment of physical or mental function attributable to the adverse event
(including prolonged or strengthened treatment, prolonged hospital stay, readmission, subsequent
hospitalization, extra outpatient department consultations or death) [11].
Causation Refers to injury caused by health care management including acts of omission (inactions) i.e. failure to
diagnose or treat, and acts of commission (affirmative actions) i.e. incorrect diagnosis or treatment,
or poor performance [11].
Health Care Management Includes the actions of individual hospital staff as well as the broader systems and care processes and
includes both acts of omission (failure to diagnose or treat) and acts of commission (incorrect
diagnosis or treatment, or poor performance) [10].
Preventable Adverse Event An injury that is caused by medical intervention or management (rather than the disease process)
and either prolonged hospital stay or caused disability at discharge, where there was
enough information currently available to have avoided the event using currently
accepted practices [16].
Higher Level of Care A higher level of care may include:
1. An unplanned transfer to an Intensive Care Unit,
2. An intervention of a Medical Emergency Team or
3. A redo procedure within 24 hours of ICU patients.
Intensive Care Units (ICUs) Hospital units providing continuous surveillance and care to actually ill patients (Mesh definition).
E.g. medical and surgical ICUs, for example Medium Care, Coronary Care Units,
Pediatric ICUs and Respiratory Care Units.
Planned ICU admissions Admissions of patients expected to arrive on the ICU.
E.g. routinely scheduled post-surgery admissions or transfers directly to the ICU from outside hospitals.
Unplanned ICU admissions All patients unexpectedly admitted to the intensive care unit from a lower level of care in the hospital
during the study period.
If a patient experienced more than one unplanned ICU admission during his/her hospital stay, each unplanned
admission is included in the analysis (adapted from Baker, 2009) [17].
Patient harm Unintended physical injury resulting from or contributed to by medical care that
requires additional monitoring, treatment or hospitalization, or
that results in death (IHI) [18].
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egories describe errors that resulted in patient harm.
An expert panel of physicians is available for second
advice when needed. In case of continued disagreement,
an independent physician, who does not review the pa-
tient records, but only the review forms, gives the final
judgment.
Case summary reports of patients that experienced an
adverse event (brief narratives of the key points of each
patient’s hospital stay) are written in order to facilitate
an overview of the cases [21].
Stage 4Analysis of causes The further analysis of the ad-
verse events fits within a broader study that aims to ex-
plore the underlying mechanisms related to the existing
safety and quality frameworks used within the hospital set-
tings. This includes insights from the organizational-wide
safety culture measurement [22]. As there is usually no
single root cause, the underlying causes and contributing
factors of the adverse events will be further explored using
the London Protocol of Root Cause Analysis [23,24].For each participating hospital, all the cases that were
assessed by the clinical team as high preventable events
are selected for further analysis. In order to conduct the
analyses, additional information is collected from a var-
iety of sources, such as for instance the availability and
quality of protocols, the accessibility of information, pa-
tient identification, training of healthcare professionals,
work patterns. . .The purpose of these analyses is to fa-
cilitate the identification of systems issues, which often
relate to structure and process (both management and
clinical processes) [25]. The strength of deconstructing
adverse events into component elements of defaults (e.g.
communication on patient information, staffing, drugs,
equipment,. . .) lies in the fact that, once identified or
characterized, potential preventive or corrective strat-
egies can be formulated.
Confidentiality
In this study anonymity of hospitals, health care provi-
ders and patients is of great importance. Several mea-
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Figure 2 Review process. Abbreviations: ICU, Intensive Care Unit; MET, Medical Emergency Team; AE, Adverse Event.
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and they are stored in a locked room or closet. Each partici-
pating hospital and each hospital admission receives a
unique study number. Patient identifiers are kept in a data-
set separately from the primary database. During the review
process in the hospitals, the data are directly entered into a
protected electronic database. The reviewers have a per-
sonal password for the electronic database. The web-based
database complies with the safety and privacy requirements.
Patients' names are not included in the database and after
completion of the data collection and analysis, patient rec-
ord identifiers are destroyed. The identity of patients or
healthcare professionals will not be revealed in research
reports [5].
If a reviewer has during the review process any con-
cern about unrecognized potential deliberate harmful
acts, illegal acts, or repetitive negligent behavior, these
concerns will be discussed with the ethics committee of
Hasselt University.The confidentiality agreement in which the confidenti-
ality and the rules for disseminations of results are speci-
fied, was established between the researchers, Hasselt
University and the participating hospitals. Therefore,
informed consent from the patients was not necessary.Ethical approval
Approval was obtained from the ethics committee of
Hasselt University and from the ethics committee of the
participant hospitals.Statistical analysis
The incidence of unplanned ICU (re)admissions and
(preventable) adverse events requiring ICU admission
will be calculated.
Primary outcomes will be measured as a rate (number of
adverse events per 1000 in-hospital patient years at risk).
The number of preventable adverse events (preventability
Table 3 Outcome measures
Determination of the presence of an adverse event is based on three criteria [4,5,10]
1. an unintended (physical and/or mental) injury which
2. results in temporary or permanent disability, death or prolongation of hospital stay, and is
3. caused by health care management rather than the patient's disease
To determine whether the injury is caused by health care management or the disease process a 6-point scale will be used [4,5,10]:
1. (Virtually) no evidence for management causation
2. Slight to modest evidence of management causation
3. Management causation not likely (less than 50/50, but 'close call')
4. Management causation more likely (more than 50/50, but 'close call')
5. Moderate to strong evidence of management causation
6. (Virtually) certain evidence of management causation
The degree of preventability of the adverse events is measured on a 6-point scale, grouped into three categories [4,5,10]:
No Preventability
1. (Virtually) no evidence for management causation
Low Preventability
1. Slight to modest evidence of management causation
2. Management causation not likely (less than 50/50, but 'close call')
High preventability
1. Management causation more likely (more than 50/50, but 'close call')
2. Moderate to strong evidence of management causation
3. (Virtually) certain evidence of management causation
Severity categories of AE’s based on the classification of the National Coordinating Council for Medication Error Reporting and Prevention
(NCC MERP) [20]. An error occurred that:
– Category E: contributed to or resulted in temporary harm to the patient and required intervention
– Category F: contributed to or resulted in temporary harm to the patient and required initial or prolonged hospitalization
– Category G: Contributed to or resulted in permanent harm
– Category H: Required intervention to sustain life
– Category I: Contributed to or resulted in the patient’s death (mortality rate)
Classification of the type of AE’s [4,19]
– Operative: an adverse event in relation to a surgical procedure or anesthesia.
– Procedural: an adverse event in relation to a non-surgical procedure such as insertion of a central venous line, nasogastric tube, cardiac
catheterization, etc.
– Anesthesia: an adverse event in relation to anesthesia.
– Diagnostic: an adverse event arising from a delayed or wrong diagnosis.
– Therapeutic: an adverse event arising when a correct diagnosis was made but there was incorrect therapy or a delay in treatment.
– Drug/intravenous fluid: an adverse event arising from the incorrect administration of a drug or intravenous fluid.
– System issue: an adverse event in relation to problems with hospital processes such as nosocomial infection or equipment malfunction.
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incidence rate.
Secondary outcomes (causality, severity) are presented as
incidence rates for each category.
A subgroup analysis will be performed on patient charac-
teristics and comorbidities, type of event, location and pro-
vider of care and type of ICU.
Testing reliability and validity
On a regular basis, the hospitals are followed up by the
researchers to discuss their problems concerning the se-
lection process of patient charts.To test the validity of the process of screening by med-
ical records analysts, 5% of all records are reviewed a
second time by the research nurse.Discussion
This paper describes the rationale for a retrospective
review study of adverse events that necessitate a
transfer to a higher level of care. More specifically,
we are particularly interested in increasing our under-
standing in the preventability and the root causes of
these events.
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to medical record review, which we are addressing
within our study design.
The most important limitation is that the use of the
method of medical record review itself might lead to an
underestimation of adverse events. The quality of the
medical records is often poor as information is missing or
incomplete. Therefore, a multidisciplinary approach, in
which the team is composed of a research nurse, phys-
ician, and clinical pharmacist which have experience in
this area, is a key condition and adds value to conducting
this chart review. A strength of our study design is the ef-
ficiency in which the members of the clinical team can
focus on their own expertise. The nurse can concentrate
on the nursing records, while the physician is focusing on
the medical records and the clinical pharmacist is examin-
ing the medication processes. Assessments on adverse
outcomes are always made collectively. In case of doubt or
disagreement, a panel of physicians with different special-
ties is available for consultation. In addition, the clinical
team assesses the completeness and usefulness of the pa-
tient charts. Incomplete records are included in the review
process, as there is a higher possibility that these cases
contain adverse events [15].
Second, there is the lack of an actual gold standard for
adverse event detection [7]. Inevitably, the clinical team
must deal with differences of medical record keeping
within the participating hospitals. We therefore attempted
to standardize our study protocol by conducting a pilot
test in one hospital over a period of two months, in which
the definitions, causality and severity ratings, abstraction
instrument and the review processes were evaluated.
Third, success of this type of research is dependent
on the acceptance and participation of organizations, pro-
fessional groups, and individuals who may be at varying
stages of readiness for investigation in this area. More spe-
cifically, the perceived threat to physician reputation or
from medico-legal action should not be underestimated
[19]. Therefore, the involvement of a physician might pro-
mote the acceptance of the method. Since the clinical team
is composed of external researchers, almost no workload is
imposed on the hospital staff and health care processes are
not interrupted. Moreover, ethical approval was obtained
by the ethical committees of the participating hospitals and
the academic institute. An agreement was signed between
the researchers, participating hospitals and the academic in-
stitute in which the privacy of the participants and the con-
fidentiality of the data is guaranteed. It is not in the
purpose of this study to compare hospitals.
Finally, although descriptive studies such as root cause
analysis have limitations, they raise important challenges
that will need to be overcome for future research to suc-
ceed [19]. From this perspective, we plan to obtain add-
itional information, such as for instance the presence ofprotocols and accessibility to information, in order to
gain additional insight in the circumstances and contrib-
uting factors leading to adverse events. Our multicenter
study design allows us to aggregate data and analyze pat-
terns of these contributing factors. Results are always
interpreted within the context of the current safety man-
agement systems in the participating hospitals and
recommendations will be formulated for the hospital
management.
Based on this study of adverse event detection, several
additional studies can be launched. It would be interesting
to link the results of this study to the hospitals administra-
tive databases to trace whether adverse events can be
properly flagged. In a later time period, a cost study can
be undertaken to assess the costs of care for patients with
an adverse event. Insights from this study can provide in-
formation for the hospital management and policy makers
to implement cost reducing interventions.
In conclusion, review of the records and further ana-
lysis of the adverse events may trigger important system
changes within the hospitals.
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